Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,229 | 29,378 | 31,465 | 25,830 | 29,487 |
| Marketable Securities | 753 | N/A | N/A | N/A | 3 |
| Receivables | 1,645 | 2,469 | 3,750 | 1,143 | 1,420 |
| Inventories | N/A | 260 | 297 | 299 | 266 |
| Other current assets | 0 | 506 | 0 | 0 | 0 |
| TOTAL | $47,237 | $34,365 | $37,004 | $28,544 | $32,405 |
| Non-Current Assets | |||||
| PPE Net | 7,539 | 6,781 | 5,652 | 2,865 | 2,858 |
| Investments And Advances | 4,671 | 0 | 0 | 0 | 0 |
| Intangibles | 33,592 | 34,906 | 36,220 | 37,534 | 38,848 |
| Other Non-Current Assets | 1,621 | 807 | 734 | 760 | 790 |
| TOTAL | $47,423 | $42,494 | $42,606 | $41,159 | $42,496 |
| Total Assets | $94,660 | $76,859 | $79,610 | $69,704 | $74,901 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,377 | 7,793 | 6,604 | 6,322 | 6,803 |
| TOTAL | $12,462 | $10,336 | $9,192 | $8,203 | $7,069 |
| Non-Current Liabilities | |||||
| Long Term Debt | 220 | 268 | N/A | N/A | N/A |
| Deferred Revenues | 2,952 | 2,147 | 2,292 | 1,653 | 208 |
| Other Non-Current Liabilities | 8,032 | 7,222 | 5,666 | 3,022 | 2,647 |
| TOTAL | $5,751 | $5,589 | $5,467 | $3,989 | $5,109 |
| Total Liabilities | $18,213 | $15,925 | $14,659 | $12,192 | $12,178 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,894 | 94,894 | 83,281 | 83,266 | 83,155 |
| Common Shares | 273,979 | 248,069 | 235,555 | 234,752 | 234,850 |
| Retained earnings | -229,893 | -215,757 | -202,055 | -192,358 | -182,190 |
| Other shareholders' equity | 50,361 | 47,622 | 47,951 | 31,611 | 26,563 |
| TOTAL | $76,447 | $60,934 | $64,951 | $57,512 | $62,723 |
| Total Liabilities And Equity | $94,660 | $76,859 | $79,610 | $69,704 | $74,901 |